Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

ANNUAL AWARD ANNOUNCED FOR MEDICAL RESEARCH CHARITIES WISHING TO BENEFIT FROM ARTIFICIAL INTELLIGENCE

BenevolentAI
Posted on: 13 Nov 17

London, UK – 13th November.  BenevolentAI, one of the world’s largest private AI companies, in partnership with the Association of Medical Research Charities (“AMRC”) announced today it has created a new award, the BenevolentAI Award, to help charities accelerate their medical research and potentially develop new treatments and therapies using artificial intelligence.

 

The Award will be given to a single applicant once a year.  BenevolentAI will offer the winning applicant access to the Company’s unique technology platform in order to solve specific research challenges the selected charity is facing.  For example, to carry out deep investigation in a specific disease, create a better understanding of the disease, identify new areas and approaches in R&D and accelerate research towards new treatments and cures.  

 

Applications for the Award open today.  The deadline for submission is 31 January 2018.  An Award judging panel consisting of Jackie Hunter, CEO of BenevolentBio, Aisling Burnand, CEO of the AMRC will access applications and choose a winner which will be announced at the AMRC & ABPI Patients First Conference on 20 March 2018.

 

Jackie Hunter, CEO of BenevolentBio, the bioscience subsidiary of BenevolentAI, commented:  “Most scientific breakthroughs are made by analysing data, but we live in a world where vast quantities of data make the discovery of new drugs and treatments for disease very difficult.  We use AI to solve this issue and want to offer medical research charities the chance to benefit from the successes we have had a a company in developing, validating and commercialising this technology.”

 

Aisling Burnand MBE, Chief Executive of the AMRC, commented: “Getting new treatments to people affected by life threatening and life limiting illnesses is of paramount importance to medical research charities. To do this we have to constantly embrace innovation, new ways of thinking, new ways of funding and use every tool in the box. Increasingly our members are recognising the vital role that advanced technology can play in accelerating their work. The opportunity to have BenevolentAI work on a project for one of our members for a year is a very exciting prospect which could give that research process a huge kick start.”

 

Full details of the Award are available on the BenevolentAI (www.benevolent.ai) and the AMRC (www.amrc.org.uk) websites. 

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 13/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.